- State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease
The ASNR Standards and Guidelines Committee reviewed new research evidence on GBCA safety and its relevance to current MRI contrast administration guidelines for patients with CKD. The recommendations for CKD patients are that there is no longer a need to withhold group II GBCAs when medically indicated for diagnosis and that it is not necessary to check renal function for these agents.
- Alternative Venous Pathways: A Potential Key Imaging Feature for Early Diagnosis of Sturge-Weber Syndrome Type 1
In this retrospective review of children with SWS, the most prevalent lesions at the first MRI were subarachnoid varicose network and transmedullary veins. The dilated venous channels are an early compensatory mechanism, preceding abnormal pial contrast enhancement, atrophy, and calcification.